The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 18, 2009
Filed:
Dec. 25, 2003
Toshiharu Ohta, Tokyo, JP;
Satoshi Komoriya, Tokyo, JP;
Toshiharu Yoshino, Tokyo, JP;
Kouichi Uoto, Tokyo, JP;
Yumi Nakamoto, Tokyo, JP;
Hiroyuki Naito, Tokyo, JP;
Akiyoshi Mochizuki, Tokyo, JP;
Tsutomu Nagata, Tokyo, JP;
Hideyuki Kanno, Tokyo, JP;
Noriyasu Haginoya, Tokyo, JP;
Kenji Yoshikawa, Tokyo, JP;
Masatoshi Nagamochi, Tokyo, JP;
Syozo Kobayashi, Tokyo, JP;
Makoto Ono, Tokyo, JP;
Toshiharu Ohta, Tokyo, JP;
Satoshi Komoriya, Tokyo, JP;
Toshiharu Yoshino, Tokyo, JP;
Kouichi Uoto, Tokyo, JP;
Yumi Nakamoto, Tokyo, JP;
Hiroyuki Naito, Tokyo, JP;
Akiyoshi Mochizuki, Tokyo, JP;
Tsutomu Nagata, Tokyo, JP;
Hideyuki Kanno, Tokyo, JP;
Noriyasu Haginoya, Tokyo, JP;
Kenji Yoshikawa, Tokyo, JP;
Masatoshi Nagamochi, Tokyo, JP;
Syozo Kobayashi, Tokyo, JP;
Makoto Ono, Tokyo, JP;
Daiichi Pharmaceutical Co., Ltd., Tokyo, JP;
Abstract
A compound represented by formula (1):Q-Q-T-N(R)-Q-N(R)-T-Q  (1)[wherein Rand Rare hydrogen atoms or the like; Qis a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Qis a single bond or the like; Qrepresents the following group: (wherein Qis an alkylene group having 1 to 8 carbon atoms, or the like); and Tand Tare carbonyl groups or the like], a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.